Evrofarma SA (EVROF.AT)
EUR 1.94
(-0.26%)
EUR 1.94
(-0.26%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 18.83 Million EUR | -4.53% |
| 2022 | 19.72 Million EUR | -6.2% |
| 2021 | 21.03 Million EUR | 17.58% |
| 2020 | 17.88 Million EUR | -2.41% |
| 2019 | 18.32 Million EUR | 2.48% |
| 2018 | 17.88 Million EUR | -9.56% |
| 2017 | 19.77 Million EUR | -1.09% |
| 2016 | 19.99 Million EUR | -4.08% |
| 2015 | 20.84 Million EUR | -6.23% |
| 2014 | 22.22 Million EUR | -4.22% |
| 2013 | 23.2 Million EUR | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 16.28 Million EUR | 0.0% |
| 2023 Q2 | 20.93 Million EUR | 0.0% |
| 2023 Q1 | 20.93 Million EUR | 5.15% |
| 2023 FY | 18.83 Million EUR | -4.53% |
| 2023 Q4 | 18.83 Million EUR | 0.0% |
| 2023 Q3 | 18.83 Million EUR | -10.02% |
| 2022 Q1 | 22.42 Million EUR | 6.63% |
| 2022 Q3 | 19.9 Million EUR | -11.24% |
| 2022 Q4 | 19.9 Million EUR | 0.0% |
| 2022 FY | 19.72 Million EUR | -6.2% |
| 2022 Q2 | 22.42 Million EUR | 0.0% |
| 2021 Q3 | 21.03 Million EUR | 9.5% |
| 2021 Q1 | 19.39 Million EUR | 8.42% |
| 2021 FY | 21.03 Million EUR | 17.58% |
| 2021 Q2 | 19.2 Million EUR | -0.96% |
| 2021 Q4 | 21.03 Million EUR | 0.0% |
| 2020 Q3 | 18.08 Million EUR | 0.03% |
| 2020 Q2 | 18.07 Million EUR | -0.59% |
| 2020 Q1 | 18.18 Million EUR | -0.77% |
| 2020 Q4 | 17.88 Million EUR | -1.08% |
| 2020 FY | 17.88 Million EUR | -2.41% |
| 2019 Q1 | 17.57 Million EUR | -1.81% |
| 2019 FY | 18.32 Million EUR | 2.48% |
| 2019 Q2 | 17.58 Million EUR | 0.03% |
| 2019 Q4 | 18.32 Million EUR | -0.56% |
| 2019 Q3 | 18.43 Million EUR | 4.83% |
| 2018 FY | 17.88 Million EUR | -9.56% |
| 2018 Q4 | 17.9 Million EUR | 0.0% |
| 2018 Q2 | 18.37 Million EUR | 0.0% |
| 2018 Q1 | 18.37 Million EUR | -7.36% |
| 2018 Q3 | 17.9 Million EUR | -2.58% |
| 2017 Q4 | 19.83 Million EUR | 0.0% |
| 2017 Q1 | 19.71 Million EUR | -6.07% |
| 2017 Q2 | 19.71 Million EUR | 0.0% |
| 2017 FY | 19.77 Million EUR | -1.09% |
| 2017 Q3 | 19.83 Million EUR | 0.62% |
| 2016 Q2 | 21.68 Million EUR | 0.0% |
| 2016 Q1 | 21.68 Million EUR | -1.11% |
| 2016 FY | 19.99 Million EUR | -4.08% |
| 2016 Q4 | 20.98 Million EUR | 0.0% |
| 2016 Q3 | 20.98 Million EUR | -3.24% |
| 2015 Q2 | 22.02 Million EUR | -1.98% |
| 2015 FY | 20.84 Million EUR | -6.23% |
| 2015 Q1 | 22.46 Million EUR | -3.79% |
| 2015 Q3 | 21.6 Million EUR | -1.91% |
| 2015 Q4 | 21.93 Million EUR | 1.51% |
| 2014 Q1 | 22.68 Million EUR | -2.27% |
| 2014 Q3 | 22.85 Million EUR | -0.26% |
| 2014 Q4 | 23.35 Million EUR | 2.21% |
| 2014 FY | 22.22 Million EUR | -4.22% |
| 2014 Q2 | 22.91 Million EUR | 1.01% |
| 2013 Q2 | 22.27 Million EUR | 0.18% |
| 2013 Q4 | 23.2 Million EUR | 2.44% |
| 2013 FY | 23.2 Million EUR | 0.0% |
| 2013 Q1 | 22.23 Million EUR | 0.0% |
| 2013 Q3 | 22.65 Million EUR | 1.7% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Flour Mills Kepenos S.A. | 23.28 Million EUR | 19.113% |
| Kri-Kri Milk Industry S.A. | -16.81 Million EUR | 212.021% |
| Loulis Food Ingredients S.A. | 55.9 Million EUR | 66.309% |